Your browser doesn't support javascript.
loading
Cellular-Level Visualization of Retinal Pathology in Multiple Sclerosis With Adaptive Optics.
Hammer, Daniel X; Kovalick, Katherine; Liu, Zhuolin; Chen, Chixiang; Saeedi, Osamah J; Harrison, Daniel M.
Afiliación
  • Hammer DX; Division of Biomedical Physics, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, United States.
  • Kovalick K; Division of Biomedical Physics, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, United States.
  • Liu Z; Department of Neurology, University of Maryland School of Medicine, Baltimore, Maryland, United States.
  • Chen C; Division of Biomedical Physics, Office of Science and Engineering Laboratories, Center for Devices and Radiological Health, U.S. Food and Drug Administration, Silver Spring, Maryland, United States.
  • Saeedi OJ; Division of Biostatistics and Bioinformatics, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland, United States.
  • Harrison DM; Department of Neurology, University of Maryland School of Medicine, Baltimore, Maryland, United States.
Invest Ophthalmol Vis Sci ; 64(14): 21, 2023 Nov 01.
Article en En | MEDLINE | ID: mdl-37971733
Purpose: To apply adaptive optics-optical coherence tomography (AO-OCT) to quantify multiple sclerosis (MS)-induced changes in axonal bundles in the macular nerve fiber layer, ganglion cell somas, and macrophage-like cells at the vitreomacular interface. Methods: We used AO-OCT imaging in a pilot study of MS participants (n = 10), including those without and with a history of optic neuritis (ON, n = 4), and healthy volunteers (HV, n = 9) to reveal pathologic changes to inner retinal cells and structures affected by MS. Results: We found that nerve fiber layer axonal bundles had 38% lower volume in MS participants (1.5 × 10-3 mm3) compared to HVs (2.4 × 10-3 mm3; P < 0.001). Retinal ganglion cell (RGC) density was 51% lower in MS participants (12.3 cells/mm2 × 1000) compared to HVs (25.0 cells/mm2 × 1000; P < 0.001). Spatial differences across the macula were observed in RGC density. RGC diameter was 15% higher in MS participants (11.7 µm) compared to HVs (10.1 µm; P < 0.001). A nonsignificant trend of higher density of macrophage-like cells in MS eyes was also observed. For all AO-OCT measures, outcomes were worse for MS participants with a history of ON compared to MS participants without a history of ON. AO-OCT measures were associated with key visual and physical disabilities in the MS cohort. Conclusions: Our findings demonstrate the utility of AO-OCT for highly sensitive and specific detection of neurodegenerative changes in MS. Moreover, the results shed light on the mechanisms that underpin specific neuronal pathology that occurs when MS attacks the retina. The new findings support the further development of AO-based biomarkers for MS.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neuritis Óptica / Esclerosis Múltiple Límite: Humans Idioma: En Revista: Invest Ophthalmol Vis Sci Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neuritis Óptica / Esclerosis Múltiple Límite: Humans Idioma: En Revista: Invest Ophthalmol Vis Sci Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos